Additional European Equity News
ArcelorMittal (MT NA) – Co. expands its portfolio of renewable energy projects in India. Total expenditure for the projects is anticipated to be approximately USD 0.9bln. (Newswires)
AstraZeneca (AZN LN) – Co. announces that Latify phase III trial has failed to meet primary endpoint in NSCLC. However, combination of Ceralasertib and Imfinzi are well tolerated. (Newswires)
Banco BPM (BAMI IM) – Co. to exercise early redemptions of EUR 400mln notes. (Newswires)
Bayer (BAYN GY) – Co.’s Finerone’s drug approved in Japan for chronic heart failure. (Newswires)
GSK (GSK LN) - Samsung Biologics (207940 KS) announced that it will acquire 100% of Human Genome Sciences from GSK (GSK LN) for USD 280mln. (Finanznachrichten)
Harbour Energy (HBR LN) - Co. announces the acquisition of LLOG Exploration for USD 3.2bln, comprised of cash and voting ordinary shares. (Harbour Energy)
Hiscox (HSX LN) – Co. announces completion of USD 275mln share repurchase programme (Newswires)
Londonmetric (LMP LN) -Co. announces GBP 91mln of investment activity. Sells GBP 64.4mln in retail assets and buys GBP 26.2mln in warehousing. (Newswires)
Nestle (NESN SW)/ Danone (BN FP) - China's Commerce Ministry is to impose levies of up to 42.2% on EU dairy products, effective 23rd December, following its anti-subsidy probe. (Newswires)
Rheinmetall (RHM GY) – Co. to supply weapon systems for Bundeswehr’s new RCH155 wheeled Howitzer with delivery to occur between 2027 and 2029. (Newswires)
Skanska (SKAB SS) - Co. has been awarded a SEK 1.1bln contract to widen the expressway in San Jacinto, California. (Newswires)
Telecom Italia (TIT IM) – Co.’s saving shareholder Davide Leone proposed terms seem adequate and expects transaction to succeed. (Newswires)
Var Energi (VAR NO) – Co. updates 2025 production guidance to 330-335 KBOEPD due to operational challenges at Johan Castberg and Balder Fields; This will be at the lower end of the previous guidance. However, 2026 production guidance remains unchanged at 400 KBOEPD. (Var Energi)
The whole workspace, free to try.
Try it free